Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentMeloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female ratsHIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats.Interactive Effects of Ethanol and HIV-1 Proteins on Novelty-Seeking Behaviors and Addiction-Related Gene ExpressionExpression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment.Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.Progression of temporal processing deficits in the HIV-1 transgenic ratHIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat.Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat OffspringModeling deficits in attention, inhibition, and flexibility in HAND.HIV-1 proteins, Tat and gp120, target the developing dopamine systemNeurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging studyAmphetamine manipulates monoamine oxidase-A level and behavior using theranostic aptamers of transcription factors AP-1/NF-kBThe HIV-1 transgenic rat model of neuroHIV.Characterization of neuropathology in the HIV-1 transgenic rat at different ages.Neuroinflammation and Behavior in HIV-1 Transgenic Rats Exposed to Chronic Adolescent Stress.PTSD co-morbid with HIV: Separate but equal, or two parts of a whole?Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.Human Immunodeficiency Virus Promotes Mitochondrial Toxicity.Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.The viral protein gp120 decreases the acetylation of neuronal tubulin: potential mechanism of neurotoxicity.Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution.Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIVMR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat.Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat.Aging alters voltage-gated calcium channels in prefrontal cortex pyramidal neurons in the HIV brain.Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV.A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.HIV-1 proteins dysregulate motivational processes and dopamine circuitry.
P2860
Q26766448-CEA372D8-C379-4EE4-9311-D5FB01B792C3Q28543458-03145FFF-EAB6-4CAA-B429-08A1E9EB6C1FQ30252876-3681FCF6-5301-40C2-B856-C29151FEB581Q30275882-37812171-B379-4E9B-BE2F-62A8A9CF3C23Q30277012-BAD07770-F2ED-4CB2-91C8-1B7EE1B0A195Q30374429-DC77F8C9-EB23-47CA-8CE9-02257CEA1CEAQ30374656-007F4C3E-2DA0-403E-ADDB-B8B5270F4688Q30397434-039F4B6C-507E-4D28-9EE6-1376ED12685DQ30431943-BB06642D-5B0F-43F7-A4AF-76F71D1A46AAQ30443006-0AD0B53C-C024-440A-9C58-CD49931C7ED7Q33601004-B0CC3C6F-1701-47A8-9391-A6337A6DB986Q34034134-4FBB25C4-1551-4139-8E03-8C31FB8B020BQ35743630-B7943304-E53F-4FDF-AB45-304DF1EFFAA2Q35968517-A33F162E-7BB9-40DA-8BB6-61AD95A971E3Q36070781-FEC5A182-8BBD-42A2-9284-48999D61211BQ36537293-134BE2CC-DFE9-4AD8-91EA-155B3A35ECC5Q36578522-E68B8552-F778-4B92-8816-E275D2580379Q36655192-B85F5A6D-DA48-4ED8-AB66-ECF862093C18Q37019473-A8DECA89-EB23-4DEA-8537-310D51FE305BQ38642340-D9196B0E-F229-4942-B8CB-7FD81D8267EBQ38916260-80AE849F-FBE6-47FD-8ECF-285F22A09886Q39427767-96FB7A06-1866-48D0-8E7E-9CFFFDE16675Q40113815-4A9F324B-62A7-43D2-908C-9F74C6FDCA8BQ40291626-4CA611FE-174F-4BA5-BA4A-26E9CB0CEBAAQ40570704-7698D589-F8A4-4908-B2BD-4E9F50C222C5Q40806200-24E0D93F-6438-4F0E-BB30-76C3F00733FFQ41274183-3C94E07F-06F5-40E2-BFDA-B19E12560449Q47160714-94048989-D572-4726-B1B9-42B0DCC396C3Q47432196-1AF91713-6F04-4A2F-B345-87029513F3C4Q47574273-92D800C4-F7E8-4BC3-971D-E59A6B0EA7ADQ47579657-3E555F30-34DC-46FB-9380-37F21E108581Q47612809-65B7DF65-EA59-44AE-9206-71D06DAFC3D3Q47989010-7445C90A-F494-44E1-ABC0-B8EF084654DAQ55309956-C62E0F23-7EBB-4B19-BE93-709EF06B96AE
P2860
Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@ast
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@en
type
label
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@ast
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@en
prefLabel
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@ast
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@en
P2093
P2860
P1476
Neurobehavioral alterations in ...... for dopaminergic dysfunction.
@en
P2093
P2860
P304
P356
10.1016/J.EXPNEUROL.2012.10.008
P407
P577
2012-10-11T00:00:00Z